Legend Biotech Announces Participation in Upcoming Investor Conferences

Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) announced participation in several key investor conferences: Citi's 17th Annual BioPharma Conference on September 7, 2022, Wells Fargo Healthcare Conference on September 8, 2022, and the Morgan Stanley Global Healthcare Conference on September 12, 2022, all featuring CEO Ying Huang, Ph.D. Additionally, the company will attend the Jefferies Cell and Genetic Medicine Summit on September 29-30, 2022. Legend Biotech focuses on developing innovative therapies for life-threatening diseases from its headquarters in Somerset, New Jersey.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, today announced its participation in the upcoming investor conferences:

Event: Citi's 17th Annual BioPharma Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Wednesday, September 7, 2022 at 11:20am ET
Presenter: Ying Huang, Ph.D., CEO

Event: 2022 Wells Fargo Healthcare Conference
Location: Boston, Massachusetts
Fireside Chat Date & Time: Thursday, September 8, 2022 at 2:35pm ET
Presenter: Ying Huang, Ph.D., CEO

Event: Morgan Stanley Global Healthcare Conference 2022
Location: New York, New York
Fireside Chat Date & Time: Monday, September 12, 2022 at 3:40pm ET
Presenter: Ying Huang, Ph.D., CEO

Event: Jefferies Cell and Genetic Medicine Summit
Location: New York, New York
Date: September 29 & 30, 2022

About Legend Biotech

Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases. Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell and natural killer (NK) cell-based immunotherapy. From our three R&D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide.

Learn more at www.legendbiotech.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220819005282/en/

Investor Contacts:

Joanne Choi, Senior Manager, Investor Relations, Legend Biotech

joanne.choi@legendbiotech.com



Crystal Chen, Manager, Investor Relations, Legend Biotech

crystal.chen@legendbiotech.com



Press Contact:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Source: Legend Biotech

FAQ

What is Legend Biotech's stock symbol?

Legend Biotech's stock symbol is LEGN.

When is Legend Biotech participating in the Citi's BioPharma Conference?

Legend Biotech will participate in the Citi's 17th Annual BioPharma Conference on September 7, 2022.

Who will present for Legend Biotech at the Wells Fargo Healthcare Conference?

CEO Ying Huang, Ph.D., will present at the Wells Fargo Healthcare Conference on September 8, 2022.

What events will Legend Biotech attend in September 2022?

In September 2022, Legend Biotech will attend the Citi's BioPharma Conference, Wells Fargo Healthcare Conference, Morgan Stanley Global Healthcare Conference, and Jefferies Cell and Genetic Medicine Summit.

Where is Legend Biotech headquartered?

Legend Biotech is headquartered in Somerset, New Jersey.